Navigation Links
Helix BioMedix, Inc. Reports 2012 Financial Results
Date:6/20/2013

Bothell, Washington (PRWEB) June 20, 2013

Helix BioMedix, Inc. (HXBM), a developer of bioactive peptides, today announced that it had posted to its website at http://www.helixbiomedix.com/investors.html an update to its stockholders along with the company’s audited year-end 2012 financial results and unaudited first quarter 2013 financial results.

The company intends to disseminate updates, financial results and other important information for stockholders by posting such information on its website at http://www.helixbiomedix.com/investors.html on a regular basis. Stockholders should monitor the company’s website on a regular basis to obtain the most current and accurate information about the company.

About Helix BioMedix, Inc.
Helix BioMedix, Inc. is a biopharmaceutical company with an extensive library of structurally diverse bioactive peptides and patents covering hundreds of thousands of peptide sequences. Core competencies include peptide design, synthesis and characterization together with assay development, screening, tissue culture and microbiology, leveraged through relationships with contract research organizations and peptide manufacturers. The company takes product development programs from theoretical concept to a qualified skin care active ingredient fully validated as to efficacy and safety. Applications for Helix BioMedix peptides include anti-aging cosmeceutical skin care and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. Apothederm, SmartPeptides, MD3 Copper, HBCeuticals and Striking are registered trademarks of Helix BioMedix, Inc.. SmartPeptide, Skin Care Science and Cerakine are trademarks of Helix BioMedix, Inc. More information about the company and its proprietary peptides may be found on the company’s website at http://www.helixbiomedix.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10856656.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
2. 1 in 3 households misreports smoke alarm coverage
3. Study examines necessity of additional imaging in PET/CT oncologic reports
4. Reactions to HIV drug have autoimmune cause, reports AIDS journal
5. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
6. Well-known author and historian reports on progress in Huntingtons therapies
7. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
8. Oxford University Press acquires joint ownership of Journal of Surgical Case Reports
9. Two-Thirds of U.S. Youth Have Had Oral Sex, CDC Reports
10. NSF reports on R&D spending by businesses in the United States
11. No July phenomenon for neurosurgery patients, reports Neurosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: